Drug Profile
Research programme: reproductive health therapeutics - Pantarhei Biosciences
Alternative Names: BLACE; OTE F; Oxytocin/estrogen - Pantarhei Biosciences; Renin angiotensin system suppressors - Pantarhei Biosciences; Testetrol - Pantarhei BiosciencesLatest Information Update: 28 Nov 2019
Price :
$50
*
At a glance
- Originator Pantarhei Bioscience
- Class Hormonal replacements; Hormones
- Mechanism of Action ACE inhibitors; Angiogenesis inhibitors; Angiotensin receptor antagonists; Estrogen receptor agonists; Oxytocin receptor agonists; Testosterone replacements
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Female testosterone deficiency; Hypogonadism; Male infertility; Menopausal syndrome
Most Recent Events
- 28 Nov 2019 No recent reports of development identified for preclinical development in Female-testosterone-deficiency in Netherlands (PO)
- 28 Nov 2019 No recent reports of development identified for preclinical development in Hypogonadism in Netherlands (PO)
- 28 Nov 2019 No recent reports of development identified for research development in Menopausal-syndrome in Netherlands